Senior Director
Cellectis
Senior Director
Cellectis
Develops allogeneic CAR-T cell therapies
Location: New York, NY (Hybrid)
Company: Cellectis
Department: Clinical Development
Position Summary
Cellectis is seeking a highly experienced Senior Director, Medical Affairs to help shape and operationalize the company’s medical affairs strategy across its clinical‑stage portfolio. Reporting to the Chief Medical Officer, this leader will elevate Cellectis’ scientific presence, support pipeline advancement, and ensure medical excellence in evidence generation, scientific communications, and external engagement.
This role is ideal for a medical affairs leader with strong immuno‑oncology expertise, strategic agility, and a passion for patient‑centered innovation.
Key Responsibilities
Education and Experience
Core Competencies
Compensation Range: $175-225k
Cellectis develops immunotherapy treatments for cancer using gene-edited allogeneic CAR T cells. Its products rely on donor-derived T cells that are edited to remove T cell receptor activity and engineered to express a chimeric antigen receptor (CAR) that targets cancer cells. The goal is to create off-the-shelf CAR T therapies that are available quickly and at a lower cost than patient-specific (autologous) CAR T treatments. Cellectis works through research and development, clinical trials, and partnerships with other pharma companies, such as Sanofi, and generates revenue from licensing, milestone payments, and potential future product sales. The company differentiates itself by offering off-the-shelf solutions rather than custom-made therapies, aiming to broaden access to advanced cancer treatment.
Explore more opportunities at Cellectis